Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The integrin alphaVbeta6 binds and activates latent TGFbeta3.

Justin P Annes1, Daniel B Rifkin, John S Munger

  • 1Department of Cell Biology, New York University School of Medicine, New York, NY 10016, USA.

FEBS Letters
|February 1, 2002
PubMed
Summary

The integrin alphaVbeta6 binds and activates latent transforming growth factor-beta3 (TGFbeta3). This finding clarifies a key step in TGFbeta signaling, revealing isoform-specific activation mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage.

Endocrine-related cancer·2026
Same author

Pseudopheochromocytoma With Catecholamine Excess and End-organ Damage: A 30-year Course Treated With Escitalopram.

JCEM case reports·2026
Same author

Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155 Induced DNA Damage.

bioRxiv : the preprint server for biology·2025
Same author

Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships.

The Journal of clinical investigation·2025
Same author

Pharmacologic stimulation of insulin granule acidification increases β-cell zinc content and augments β-cell-targeted drug delivery.

The Journal of biological chemistry·2025

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factors-beta (TGFbeta1, 2, and 3) are secreted with latency-associated peptides (LAP1, 2, and 3).
  • TGFbeta signaling activation necessitates the dissociation of LAP from TGFbeta, a process known as latent TGFbeta activation.
  • The precise mechanisms of latent TGFbeta activation and potential isoform-specific differences remain incompletely understood.

Purpose of the Study:

  • To investigate the mechanisms regulating latent TGFbeta activation.
  • To explore potential differences in activation mechanisms among TGFbeta isoforms.
  • To determine the role of alphaVbeta6 in latent TGFbeta3 activation.

Main Methods:

  • Investigated the interaction between alphaVbeta6 and latent TGFbeta3.

Related Experiment Videos

  • Assessed the ability of alphaVbeta6 to activate latent TGFbeta3.
  • Utilized biochemical and cell-based assays to study TGFbeta activation.

    • Main Results:

    • Demonstrated that the integrin alphaVbeta6 specifically binds to latent TGFbeta3.
    • Showed that alphaVbeta6 binding leads to the activation of latent TGFbeta3.
    • Provided evidence for isoform-specific regulation of TGFbeta activation.

    Conclusions:

    • The integrin alphaVbeta6 plays a direct role in the activation of latent TGFbeta3.
    • This interaction highlights a specific mechanism for activating the TGFbeta3 isoform.
    • Understanding these isoform-specific activation pathways is crucial for regulating TGFbeta function.